Last update 26 Oct 2026

GST HG 151

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
GST HG151, GST-HG151
Target
ASK1 x JNK x p38 MAPK
Action
inhibitors
Mechanism
ASK1 inhibitors(Apoptosis signal-regulating kinase 1 inhibitors), JNK inhibitors(c-Jun N-terminal kinase inhibitors), p38 MAPK stimulants(P38丝裂原活化蛋白激酶刺激剂)
Therapeutic Areas
Digestive System DisordersOther Diseases
Active Indication
FibrosisMetabolic Dysfunction Associated Steatohepatitis
Inactive Indication-
Originator Organization
Fujian Cosunter Pharmaceutical Co., Ltd.Fujian Cosunter Pharmaceutical Co., Ltd.
Active Organization
Fujian Cosunter Pharmaceutical Co., Ltd.Fujian Cosunter Pharmaceutical Co., Ltd.Fujian Guangsheng Zhonglin Biotechnology Co., Ltd.Fujian Guangsheng Zhonglin Biotechnology Co., Ltd.
Inactive Organization-
License Organization
Fujian Cosunter Pharmaceutical Co., Ltd.Fujian Cosunter Pharmaceutical Co., Ltd.WuXi AppTec (Shanghai) Co. Ltd.WuXi AppTec (Shanghai) Co. Ltd.
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with GST HG 151
NCT05345964
/ Unknown statusPhase 1
A Safety, Tolerability, Pharmacokinetics, and Food Impact Phase I Study of GST-HG151 Tablets in Single-dose and Multiple-dose in Healthy Volunteers
100 Clinical Results associated with GST HG 151
Login to view more data
100 Translational Medicine associated with GST HG 151
Login to view more data
100 Patents (Medical) associated with GST HG 151
Login to view more data
100 Deals associated with GST HG 151
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
FibrosisPhase 1-
Fujian Guangsheng Zhonglin Biotechnology Co., Ltd.Fujian Guangsheng Zhonglin Biotechnology Co., Ltd.
01 Oct 2026
Metabolic Dysfunction Associated SteatohepatitisPhase 1
China
Fujian Cosunter Pharmaceutical Co., Ltd.Fujian Cosunter Pharmaceutical Co., Ltd.
07 Mar 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free